These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 29664198
41. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Moreira Júnior G, Bordin JO, Kuroda A, Kerbauy J. Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087 [Abstract] [Full Text] [Related]
42. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria. Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE. Niger J Clin Pract; 2015 Jul; 18(4):522-6. PubMed ID: 25966726 [Abstract] [Full Text] [Related]
43. Mechanisms of alloimmunization in sickle cell disease. Hudson KE, Fasano RM, Karafin MS, Hendrickson JE, Francis RO. Curr Opin Hematol; 2019 Nov; 26(6):434-441. PubMed ID: 31483335 [Abstract] [Full Text] [Related]
44. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion. Jariwala K, Mishra K, Ghosh K. Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372 [Abstract] [Full Text] [Related]
45. Red blood cell alloimmunization mitigation strategies. Hendrickson JE, Tormey CA, Shaz BH. Transfus Med Rev; 2014 Jul; 28(3):137-44. PubMed ID: 24928468 [Abstract] [Full Text] [Related]
46. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830 [Abstract] [Full Text] [Related]
48. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center. Hindawi S, Badawi M, Elfayoumi R, Elgemmezi T, Al Hassani A, Raml M, Alamoudi S, Gholam K. Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130 [Abstract] [Full Text] [Related]
52. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature. Yuan S, Ewing NP, Bailey D, Salvador M, Wang S. Immunohematology; 2007 Feb; 23(2):75-80. PubMed ID: 18004938 [Abstract] [Full Text] [Related]
55. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis. Godfrey GJ, Lockwood W, Kong M, Bertolone S, Raj A. Pediatr Blood Cancer; 2010 Dec 01; 55(6):1134-7. PubMed ID: 20979172 [Abstract] [Full Text] [Related]
56. Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion. Roberts DO, Covert B, Lindsey T, Edwards V, McLaughlin L, Theus J, Wray RJ, Jupka K, Baker D, Robbins M, DeBaun MR. Immunohematology; 2012 Dec 01; 28(1):7-12. PubMed ID: 22646143 [Abstract] [Full Text] [Related]
57. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching. Ang AL, Lim CY, Ng WY, Lam JCM. Transfusion; 2021 Sep 01; 61(9):2566-2577. PubMed ID: 34258773 [Abstract] [Full Text] [Related]
60. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia. Fabron A, Moreira G, Bordin JO. Sao Paulo Med J; 1999 Jan 07; 117(1):38-9. PubMed ID: 10413970 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]